CD274 and non-small cell lung carcinoma: We retrospectively analyzed oncologic outcomes for patients with NSCLC and HNSCC treated with PD-1 and PD-L1 ICIs at these equal access institutions in order to determine whether racial and/or ethnic disparities are present.